196 related articles for article (PubMed ID: 24852215)
1. Chitosan and silver nanoparticles: promising anti-toxoplasma agents.
Gaafar MR; Mady RF; Diab RG; Shalaby TI
Exp Parasitol; 2014 Aug; 143():30-8. PubMed ID: 24852215
[TBL] [Abstract][Full Text] [Related]
2. Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis.
Gaafar MR; El-Zawawy LA; El-Temsahy MM; Shalaby TI; Hassan AY
Exp Parasitol; 2019 Dec; 207():107772. PubMed ID: 31610183
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Hagras NA; Allam AF; Farag HF; Osman MM; Shalaby TI; Fawzy Hussein Mogahed NM; Tolba MM; Shehab AY
Exp Parasitol; 2019 Sep; 204():107717. PubMed ID: 31228418
[TBL] [Abstract][Full Text] [Related]
4. Effect of Nigella sativa oil on experimental toxoplasmosis.
Mady RF; El-Hadidy W; Elachy S
Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
[TBL] [Abstract][Full Text] [Related]
5. Anti-
Teimouri A; Azami SJ; Keshavarz H; Esmaeili F; Alimi R; Mavi SA; Shojaee S
Int J Nanomedicine; 2018; 13():1341-1351. PubMed ID: 29563791
[TBL] [Abstract][Full Text] [Related]
6. High Efficacy of Green Synthesized Silver Nanoparticles for Treatment of Toxoplasma Gondii Infection Through Their Immunomodulatory, Anti-Inflammatory, and Antioxidant Potency.
Majeed QAH; Alnomasy SF; Shater AF; Alanazi AD
Acta Parasitol; 2024 Jun; 69(2):1201-1211. PubMed ID: 38634986
[TBL] [Abstract][Full Text] [Related]
7. 6-trifluoromethyl-2-thiouracil possesses anti-Toxoplasma gondii effect in vitro and in vivo with low hepatotoxicity.
Choi HJ; Yu ST; Lee KI; Choi JK; Chang BY; Kim SY; Ko MH; Song HO; Park H
Exp Parasitol; 2014 Aug; 143():24-9. PubMed ID: 24830752
[TBL] [Abstract][Full Text] [Related]
8. Anti-
Alajmi RA; Al-Megrin WA; Metwally D; Al-Subaie H; Altamrah N; Barakat AM; Abdel Moneim AE; Al-Otaibi TT; El-Khadragy M
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992387
[TBL] [Abstract][Full Text] [Related]
9. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.
El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
Exp Parasitol; 2015 Feb; 149():54-64. PubMed ID: 25499511
[TBL] [Abstract][Full Text] [Related]
10. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies.
El Zawawy LA
J Egypt Soc Parasitol; 2008 Apr; 38(1):185-201. PubMed ID: 19143130
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
[TBL] [Abstract][Full Text] [Related]
12. Effects of Aloe vera and Eucalyptus methanolic extracts on experimental toxoplasmosis in vitro and in vivo.
Mirzaalizadeh B; Sharif M; Daryani A; Ebrahimzadeh MA; Zargari M; Sarvi S; Mehrzadi S; Rahimi MT; Mirabediny Z; Golpour M; Montazeri M
Exp Parasitol; 2018 Sep; 192():6-11. PubMed ID: 30031121
[TBL] [Abstract][Full Text] [Related]
13. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
15. Could miltefosine be used as a therapy for toxoplasmosis?
Eissa MM; Barakat AM; Amer EI; Younis LK
Exp Parasitol; 2015 Oct; 157():12-22. PubMed ID: 26112396
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii.
Dantas-Leite L; Urbina JA; de Souza W; Vommaro RC
Int J Antimicrob Agents; 2005 Feb; 25(2):130-5. PubMed ID: 15664482
[TBL] [Abstract][Full Text] [Related]
17. Promising
Esboei BR; Keighobadi M; Hezarjaribi HZ; Fakhar M; Daryani A; Chabra A; Soosaraei M; Yalveh R
Infect Disord Drug Targets; 2021; 21(1):151-155. PubMed ID: 32389115
[TBL] [Abstract][Full Text] [Related]
18. Activity of gatifloxacin alone or in combination with pyrimethamine or gamma interferon against Toxoplasma gondii.
Khan AA; Slifer TR; Araujo FG; Remington JS
Antimicrob Agents Chemother; 2001 Jan; 45(1):48-51. PubMed ID: 11120943
[TBL] [Abstract][Full Text] [Related]
19. The effect of sulfomethoxypyrazine-pyrimethamine therapy on the fine structure of Toxoplasma gondii-cysts in the brain of Mastomys natalensis. Scanning and transmission electron microscopical investigations.
Matuschka FR
Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):419-29. PubMed ID: 910581
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles show potential to retard bradyzoites in vitro formation of Toxoplasma gondii.
Adeyemi OS; Murata Y; Sugi T; Han Y; Kato K
Folia Parasitol (Praha); 2019 Feb; 66():. PubMed ID: 30799835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
